The effect of using ursodeoxycholic acid in incident of gallstone in laparoscopic sleeve gastrectomy

Comparison of using ursodeoxycholic acid and using placebo in incident of gallstone after laparoscopic gastrectomy

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200708048049N1

Enrollment

100

Registered

2020-08-12

Start date

2020-01-21

Completion date

Unknown

Last updated

2020-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Morbid obesity. Other obesity

Interventions

Intervention 1: Intervention group:Treated with using ursodeoxycholic (kushan pharmed, Tehran, Iran) daily. Intervention 2: Control group:Treated with using placebo daily.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: - patients undergoing Laparoscopic sleeve gastrectomy - morbid obesity (BMI more than 40 kg/m2 in healthy people and more than 35 kg/m2 with comorbidity)

Exclusion criteria

Exclusion criteria: - patient with past history of cholecystectomy - patient with gallbladder agenesia -patient who didn't sign the consent form.

Design outcomes

Primary

Measure	Time frame
Gallstone. Timepoint: Before sleeve gastrectomy surgery, 6 and 12 months after surgery. Method of measurement: Ultrasound.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNasser Malekpour Alamdari

Shahid Beheshti University of Medical Sciences

nassermalekpour@sbmu.ac.ir+98 21 2207 4089

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026